Propacetamol

Overview

Propacetamol is an orally active prodrug of Acetaminophen ( HY-66005 ), which exerts antipyretic and analgesic effects after metabolism. Propacetamol reduces Aspirin (ASA) ( HY-14654 )-induced elevation of malondialdehyde ( MDA ) in gastric mucosa and plasma, regulates the levels of gastric mucosal glutathione ( GSH and GSSG ) to maintain cellular antioxidant defense, and increases gastric mucosal uric acid ( UA ) levels. Propacetamol exerts a dose-dependent protective effect against ASA-induced gastric mucosal damage in rats. Propacetamol can be used for the study of gastric mucosal injury by interfering with oxidative stress.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-145453
• CAS No.: 66532-85-2
• Molecular Formula: C14H20N2O3
• Molecular Weight: 264.32
• Purity: 98.02%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (9.46 mM); Clear solution
• Availability: In-stock

Source

Original product source